Literature DB >> 8538575

Molecular and immunological characterization of the p83/100 protein of various Borrelia burgdorferi sensu lato strains.

D Rössler1, H Eiffert, S Jauris-Heipke, G Lehnert, V Preac-Mursic, J Teepe, T Schlott, E Soutschek, B Wilske.   

Abstract

The complete coding regions of the chromosomally encoded p83/100 protein of four Borrelia garinii strains and one Borrelia burgdorferi sensu stricto strain have been amplified by the polymerase chain reaction (PCR), cloned and sequenced. From alignment studies with the deduced amino acid sequences presented here, and five other published p83/100 sequences, the most heterologous region of the p83/100 molecule was identified to be located between amino acid position 390-540. To study the structure of this heterogeneous region, and internal fragment of the p83/100 genes from 11 additional B. burgdorferi sensu lato strains was amplified by PCR. The PCR products were analyzed by DNA sequencing and restriction enzyme analysis. These internal p83/100 fragments varied in size and sequence. Cluster analysis of internal p83/100 fragments, as well as restriction enzyme analysis, revealed three major groups in accordance with grouping into the three species causing Lyme disease. Strains within the same species (six B. burgdorferi sensu stricto and six B. afzelii strains) showed similar p83/100 partial structures. Nevertheless, nine B. garinii strains showed more sequence variations and could be further divided into two major subgroups. One group is represented by OspA serotype 4 strains, the other more heterogeneous group is represented by OspA serotypes 3, 5, 6 and 7 strains. Phenotypic analysis with four p83/100-specific monoclonal antibodies revealed four distinct reactivity patterns. Antibody L100 1B4 recognized a common epitope of B. burgdorferi sensu stricto and B. afzelii. Antibodies L100 17D3 and L100 18B4 were reactive with an epitope shared by strains of all three species. The broadest reactivity was shown by L100 18B4 which, in contrast to L100 17D3, additionally recognized the relapsing fever borreliae B. turicatae and B. hermsii. L100 8B8 detected a subgroup of the B. burgdorferi sensu stricto strains. Since comparison of the p83/100 molecule with sequences from protein databases showed similarities with characteristics of eukaryotic cell structures, the p83/100 might mimic these structures and may, therefore, be involved in the immune escape mechanism of the pathogenic agent of Lyme disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8538575     DOI: 10.1007/bf00216786

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  38 in total

Review 1.  Antigenic variation and strain heterogeneity in Borrelia spp.

Authors:  B Wilske; A G Barbour; S Bergström; N Burman; B I Restrepo; P A Rosa; T Schwan; E Soutschek; R Wallich
Journal:  Res Microbiol       Date:  1992 Jul-Aug       Impact factor: 3.992

2.  Lyme borreliosis: host responses to Borrelia burgdorferi.

Authors:  A Szczepanski; J L Benach
Journal:  Microbiol Rev       Date:  1991-03

3.  Analysis and expression of the Borrelia burgdorferi P/Gau fla gene: identification of heterogeneity with the B31 strain.

Authors:  B J Luft; S Pawagi; W Jiang; S Fiseene; P D Gorevic; J Dunn
Journal:  FEMS Microbiol Lett       Date:  1992-05-15       Impact factor: 2.742

4.  Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis.

Authors:  G Baranton; D Postic; I Saint Girons; P Boerlin; J C Piffaretti; M Assous; P A Grimont
Journal:  Int J Syst Bacteriol       Date:  1992-07

5.  Phenotypic analysis of outer surface protein C (OspC) of Borrelia burgdorferi sensu lato by monoclonal antibodies: relationship to genospecies and OspA serotype.

Authors:  B Wilske; S Jauris-Heipke; R Lobentanzer; I Pradel; V Preac-Mursic; D Rössler; E Soutschek; R C Johnson
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

6.  Molecular analysis of the outer surface protein A (OspA) of Borrelia burgdorferi for conserved and variable antibody binding domains.

Authors:  B Wilske; B Luft; W H Schubach; G Zumstein; S Jauris; V Preac-Mursic; M D Kramer
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

7.  Use of a hybrid protein consisting of the variable region of the Borrelia burgdorferi flagellin and part of the 83-kDa protein as antigen for serodiagnosis of Lyme disease.

Authors:  C Rasiah; S Rauer; G S Gassmann; A Vogt
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

8.  Polymerase chain reaction primers and probes derived from flagellin gene sequences for specific detection of the agents of Lyme disease and North American relapsing fever.

Authors:  R N Picken
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

9.  Antibodies against Borrelia burgdorferi in Bavarian forest workers.

Authors:  P Münchhoff; B Wilske; V Preac-Mursic; G Schierz
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1987-02

10.  Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection.

Authors:  B J Luft; C R Steinman; H C Neimark; B Muralidhar; T Rush; M F Finkel; M Kunkel; R J Dattwyler
Journal:  JAMA       Date:  1992-03-11       Impact factor: 56.272

View more
  11 in total

1.  BB0744 Affects Tissue Tropism and Spatial Distribution of Borrelia burgdorferi.

Authors:  Beau Wager; Dana K Shaw; Ashley M Groshong; Jon S Blevins; Jon T Skare
Journal:  Infect Immun       Date:  2015-07-06       Impact factor: 3.441

2.  Impact of strain heterogeneity on Lyme disease serology in Europe: comparison of enzyme-linked immunosorbent assays using different species of Borrelia burgdorferi sensu lato.

Authors:  U Hauser; H Krahl; H Peters; V Fingerle; B Wilske
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

3.  Interpretation criteria for standardized Western blots for three European species of Borrelia burgdorferi sensu lato.

Authors:  U Hauser; G Lehnert; R Lobentanzer; B Wilske
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

4.  Treatment with Doxycycline of Generalized Annular Elastolytic Giant Cell Granuloma Associated with Borrelia burgdorferi Infection.

Authors:  B Tas; A Caglar; B Ozdemir
Journal:  West Indian Med J       Date:  2015-05-05       Impact factor: 0.171

5.  Distribution of Borrelia burgdorferi sensu lato genomic groups in Europe, a review.

Authors:  Z Hubálek; J Halouzka
Journal:  Eur J Epidemiol       Date:  1997-12       Impact factor: 8.082

6.  Heterogeneity of BmpA (P39) among European isolates of Borrelia burgdorferi sensu lato and influence of interspecies variability on serodiagnosis.

Authors:  D Roessler; U Hauser; B Wilske
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

7.  Three species of Borrelia burgdorferi sensu lato (B. burgdorferi sensu stricto, B afzelii, and B. garinii) identified from cerebrospinal fluid isolates by pulsed-field gel electrophoresis and PCR.

Authors:  U Busch; C Hizo-Teufel; R Boehmer; V Fingerle; H Nitschko; B Wilske; V Preac-Mursic
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

8.  Diversity of OspA and OspC among cerebrospinal fluid isolates of Borrelia burgdorferi sensu lato from patients with neuroborreliosis in Germany.

Authors:  B Wilske; U Busch; H Eiffert; V Fingerle; H W Pfister; D Rössler; V Preac-Mursic
Journal:  Med Microbiol Immunol       Date:  1996-02       Impact factor: 3.402

9.  Sequence analysis of ospA genes shows homogeneity within Borrelia burgdorferi sensu stricto and Borrelia afzelii strains but reveals major subgroups within the Borrelia garinii species.

Authors:  G Will; S Jauris-Heipke; E Schwab; U Busch; D Rössler; E Soutschek; B Wilske; V Preac-Mursic
Journal:  Med Microbiol Immunol       Date:  1995-08       Impact factor: 3.402

10.  Diagnostic value of proteins of three Borrelia species (Borrelia burgdorferi sensu lato) and implications for development and use of recombinant antigens for serodiagnosis of Lyme borreliosis in Europe.

Authors:  U Hauser; G Lehnert; B Wilske
Journal:  Clin Diagn Lab Immunol       Date:  1998-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.